Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center, Single-arm, Prospective, Open-label, Pilot Clinical Trial to Evaluate the Safety and Efficacy of the Focused Ultrasound Stimulator System (NMS-01) for Transient Blood-Brain Barrier (BBB) Opening in Patients With Mild to Moderate Alzheimer's Disease

NCT07869238 is registered in ClinicalTrials.gov with Neumous Inc. as lead sponsor.

NCT NCT07869238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07869238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center, Single-arm, Prospective, Open-label, Pilot Clinical Trial to Evaluate the Safety and Efficacy of the Focused Ultrasound Stimulator System (NMS-01) for Transient Blood-Brain Barrier (BBB) Opening in Patients With Mild to Moderate Alzheimer's Disease
Lead sponsor
Neumous Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
January 5, 2026
Completion date
November 30, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, blood brain barrier